Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Date of Graduation
12-12-2025
Semester of Graduation
Fall
Course Instructor
Laura Mae Tice
Abstract
Asthma and COPD are two common chronic respiratory diseases that have the potential to result in acute life-threatening exacerbations1. These episodes cost America’s healthcare system several billions of dollars annually and can be largely prevented through proper medication adherence2. Objective: Assess the effectiveness of smart inhaler usage and biofeedback interpretation with medication adherence and quality of Asthma and/or COPD control. Design: Systematic literature review. Methods: Searches were done in PubMed, Wiley Online Library, ScienceDirect Database, and DynaMed utilizing the terms smart inhaler, asthma/COPD management, biofeedback, inhalation technique, SABA, LABA, and LAMA. In PubMed, the following limits and terms were used: published within 10 years, randomized control trials (RCTs), adult population, US or similar geographical location, and English. Results: Three studies met inclusion/exclusion criteria: Sulaiman et al., Moore et al., and O’Dwyer et al. Conclusion: The use of smart inhalers and biofeedback is a safe and efficient way to improve medication adherence among patients with asthma and/or COPD. Factors necessary for proper management such as frequency of use and technique can be evaluated and utilized with smart inhalers. Implementation of these devices in clinical practice as well as research on cost-effectiveness should be discussed in future studies.
Recommended Citation
1. Hartert T, Bacharier L, Wood R, Bochner B. An overview of asthma management in children and adults. UpToDate. Published online September 30, 2024. Accessed October 11, 2024. https://www.uptodate.com/contents/an-overview-of-asthma-management-in-children-and-adults?search=An%20overview%20of%20asthma%20management%20in%20children%20and%20adults&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1 2. Trevor J, Lugogo N, Carr W, et al. Severe asthma exacerbations in the United States: Incidence, characteristics, predictors, and effects of biologic treatments. Annals of Allergy, Asthma, and Immunology. 2021;127(5):579-587. doi:10.1016/j.anai.2021.07.010 3. Barnett SL, Nurmagambetov T. Costs of asthma in the United States: 2002-2007. The Journal of Allergy and Clinical Immunology. 2011;127(1):145-152 doi:10.1016/j.jaci.2010.10.020 4. O'Dwyer S, Greene G, MacHale E, et al. Personalized biofeedback on inhaler adherence and technique by community pharmacists: A cluster randomized clinical trial. The Journal of Allergy and Clinical Immunology. 2020;8(2):635-644. doi:10.1016/j.jaip.2019.09.008 5. Sulaiman I, Greene G, MacHale E, et al. A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma. European Respiratory Journal 2018;51(1):1701126. doi:https://doi.org/10.1183/13993003.01126-2017 6. Moore A, Preece A, Sharma R, et al. A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients. European Respiratory Journal 2021;57(6):2003103; doi:https://doi.org/10.1183/13993003.03103-2020
